Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
International Journal of Cancer
|
December 4, 2008
Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy-related genes
Bengt Gustavsson, Christopher Kaiser, Göran Carlsson, et al.
Seminars in Oncology
|
February 7, 2003
Pemetrexed safety and dosing strategy
Clet Niyikiza, Axel-R Hanauske, James J Rusthoven, et al.
Investigational New Drugs
|
May 31, 2007
In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression
Axel-Rainer Hanauske, Ulrike Eismann, Olaf Oberschmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2003
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
Nicholas J Vogelzang, James J Rusthoven, James Symanowski, et al.
Molecular Cancer Therapeutics
|
December 14, 2002
Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy
Clet Niyikiza, Sharyn D Baker, David E Seitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2023
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
Nicholas J Vogelzang, James J Rusthoven, James Symanowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2006
A phase II trial of pemetrexed in advanced breast cancer: clinical response and association with molecular target expression
Henry L Gomez, Sergio L Santillana, Carlos S Vallejos, et al.
Clinical Lung Cancer
|
November 24, 2004
Expression levels of protein kinase C-alpha in non-small-cell lung cancer
Michael Lahn, Chen Su, Shuyu Li, et al.
Toxicology and Applied Pharmacology
|
June 9, 2012
HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity
Joseph G Reynolds, Elena Geretti, Bart S Hendriks, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 27, 2021
Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation
Paul-Michel Mertes, Olivier Collange, Pierre Coliat, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
International Journal of Cancer
|
December 4, 2008
Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy-related genes
Bengt Gustavsson, Christopher Kaiser, Göran Carlsson, et al.
Seminars in Oncology
|
February 7, 2003
Pemetrexed safety and dosing strategy
Clet Niyikiza, Axel-R Hanauske, James J Rusthoven, et al.
Investigational New Drugs
|
May 31, 2007
In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression
Axel-Rainer Hanauske, Ulrike Eismann, Olaf Oberschmidt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2003
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
Nicholas J Vogelzang, James J Rusthoven, James Symanowski, et al.
Molecular Cancer Therapeutics
|
December 14, 2002
Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy
Clet Niyikiza, Sharyn D Baker, David E Seitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2023
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
Nicholas J Vogelzang, James J Rusthoven, James Symanowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2006
A phase II trial of pemetrexed in advanced breast cancer: clinical response and association with molecular target expression
Henry L Gomez, Sergio L Santillana, Carlos S Vallejos, et al.
Clinical Lung Cancer
|
November 24, 2004
Expression levels of protein kinase C-alpha in non-small-cell lung cancer
Michael Lahn, Chen Su, Shuyu Li, et al.
Toxicology and Applied Pharmacology
|
June 9, 2012
HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity
Joseph G Reynolds, Elena Geretti, Bart S Hendriks, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 27, 2021
Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation
Paul-Michel Mertes, Olivier Collange, Pierre Coliat, et al.
Page
of 1